Kami J. Maddocks, MD

Videos

Approaches to Frontline Therapy for Patients With Mantle Cell Lymphoma: Part 2

11/09/2023

In the second part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on goals and choice of frontline therapy for patients with mantle cell lymphoma.

In the second part of an expert...

11/09/2023

Oncology

How Do I Manage the Patient with Advanced Stage Hodgkin Lymphoma and What Do I Do at First Relapse?

Kami J. Maddocks , MD;

08/29/2020

Videos

Addition of Venetoclax to Lenalidomide and Rituximab Therapy for Patients With Previously Untreated MCL

09/22/2023

Kami J. Maddocks , MD;

Kami J. Maddocks, MD, discusses results from a single-arm study on the addition of venetoclax to a lenalidomide and rituximab regimen for patients with previously untreated mantle cell lymphoma.

Kami J. Maddocks, MD, discusses...

09/22/2023

Oncology

Debate: How to Best Manage Patients with Relapsed Mantle Cell Lymphoma?

Kami J. Maddocks , MD;

08/29/2020

Videos

New Possibilities and Advances in Mantle Cell Lymphoma Treatment: Part 5

11/13/2023

Jia Ruan , MD, PhD;

Kami J. Maddocks , MD;

Krish Patel , MD;

Kami Maddocks, MD, reviews new possibilities and the latest advances in the treatment of patients with mantle cell lymphoma with Jia Ruan, MD, PhD, and Krish Patel, MD.

Kami Maddocks, MD, reviews new...

11/13/2023

Oncology

What’s New in Upfront Mantle Cell Lymphoma Approaches?

Kami J. Maddocks , MD;

08/29/2020

How Do I Manage the Patients With Advanced Stage Hodgkin Lymphoma and What Do I Do at First Relapse?

Kami J. Maddocks , MD;

03/10/2020

Debate: How Best to Manage Patients With Relapsed Mantle Cell Lymphoma?: Ibrutinib-Based Therapy Alone or in Combination

Kami J. Maddocks , MD;

03/10/2020

What's New in Upfront Mantle Cell Lymphoma Approaches?

Kami J. Maddocks , MD;

03/10/2020

Videos

Pirtobrutinib Demonstrates Durable Efficacy and Safety Among Patients With Covalent BTK Inhibitor Pretreated R/R MCL

09/05/2023

Kami J. Maddocks , MD;

Kami J. Maddocks, MD, analyzes the updated results of the BRUIN trial on the efficacy and safety of pirtobrutinib among patients with high-risk heavily pretreated R/R mantle cell lymphoma with prior covalent BTK inhibitor therapy.

Kami J. Maddocks, MD, analyzes...

09/05/2023

Oncology